You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (43) |
Back to Search
REAL-WORLD EFFECTIVENESS AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIASIS
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-014
- By: CANO DOMíNGUEZ, Sergio (Hospital Universitario Virgen de las Nieves, Hospital pharmacy, Spain)
- Co-author(s): Sergio Cano Domínguez: Farmacia del hospital, Hospital Universitario Virgen de las Nieves, Granada,
Misael Rodríguez Goicoechea : Farmacia del hospital, Hospital Universitario Virgen de las Nieves, Granada,
Sara Guijarro Herrera: Farmacia del hospital, Hospital Universitario Virgen de las Nieves, Granada,
Eduardo Tejedor Tejada: Hospital pharmacy, Hospital Universitario Torrecárdenas, Almería, Spain - Abstract:
Background
Ixekizumab is a recently approved interleukin 17A inhibitor indicated for the treatment of patients with plaque psoriasis and psoriatic arthritis.
Purpose
Assess effectiveness and safety of ixekizumab in patients with psoriasis.
Methods
Retrospective, observational study performed in a third-level hospital. Patients with
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026